Italfarmaco - About the company
Italfarmaco is an unfunded company based in Milan (Italy), founded in 1938. It operates as a Manufacturer of prescription and over-the-counter pharmaceutical products. Italfarmaco has not raised any funding yet. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.
Company Details
Manufacturer of prescription and over-the-counter pharmaceutical products. This company develops, manufactures, and markets these products, with a focus on treatments for rare diseases. The manufacturing process is overseen from start to finish to ensure quality. Research and development efforts concentrate on identifying new dosing solutions for existing drugs, reformulating existing medications, and developing active pharmaceutical ingredients for generic medicines. The company's production facilities manufacture various product forms, including injectables, solid and liquid oral medications, and semi-solid products.
- Website
- www.italfarmaco.com/
- Phone Number
- +39 **********
Key Metrics
Founded Year
1938
Location
Milan, Italy
Stage
Unfunded
Ranked
177th among 1239 active competitors
Employee Count
11 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Italfarmaco's company profile
Italfarmaco's funding and investors
Italfarmaco has not raised any funding rounds yet.
Italfarmaco's founders and board of directors
Founder? Claim ProfileItalfarmaco's employee count trend
Italfarmaco has 11 employees as of Sep 26. Here is Italfarmaco's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Italfarmaco's Competitors and alternates
Top competitors of Italfarmaco include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Italfarmaco, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public | Traditional company engaged in manufacturing generics | $500M | 75/100 | |
3rd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
4th | Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
5th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
6th | The Alvogen 2009, Morristown (United States), Acquired | Developer and marketer of pharmaceutical products | $156M | 69/100 | |
7th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
8th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
9th | Laboratorio Reig Jofre 2000, Barcelona (Spain), Public | Manufacturer of pharmaceutical products and food supplements | - | 68/100 | |
10th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
177th | Italfarmaco 1938, Milan (Italy), Unfunded | Manufacturer of prescription and over-the-counter pharmaceutical products | - | - | 45/100 |
Looking for more details on Italfarmaco's competitors? Click here to see the top ones
Italfarmaco's Investments and acquisitions
Italfarmaco has acquired Lacer. Italfarmaco has not made any investments as of now.News related to Italfarmaco
Media has covered Italfarmaco for a total of 7 events in the last 1 year, 3 of them have been about company updates and 2 about partnerships.
•
Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare DiseasesBusiness Wire•Oct 05, 2026•VeriSIM Life, Italfarmaco
•
Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for Novel Therapy for Hunter SyndromeBusiness Wire•Oct 02, 2026•Italfarmaco, JCR Pharmaceuticals
•
Italfarmaco Presents New Givinostat Clinical Data in Duchenne Muscular Dystrophy at World Muscle Society CongressGlobeNewswire•Sep 30, 2026•Italfarmaco
•
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat to Treat Duchenne Muscular DystrophyGlobeNewswire•Jul 31, 2026•Italfarmaco
•
Italfarmaco Presents New Clinical Data on Givinostat for Duchenne Muscular Dystrophy at ICNMD 2026GlobeNewswire•Jul 07, 2026•Italfarmaco
•
Italfarmaco announces Health Canada's acceptance of Priority Review for Givinostat's New Drug Submission for Duchenne Muscular DysGlobeNewswire•Jun 10, 2026•Italfarmaco
•
Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare DiseaseBusiness Wire•Dec 24, 2025•JCR Pharmaceuticals, Italfarmaco
•
•
New Givinostat Data for Duchenne Muscular Dystrophy Presented at 2025 World Muscle Society CongressGlobeNewswire•Oct 07, 2025•Italfarmaco
•
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in BrazilGlobeNewswire•Sep 16, 2025•Italfarmaco
Are you a Founder ?
FAQs about Italfarmaco
Explore our recently published companies
- GreenFlow Solutions - Canada based, 2024 founded, Unfunded company
- Terrolight Pharmaceuticals - Jodhpur based, 2016 founded, Deadpooled company
- Digital Vision Pharma - Sirmaur based, 2009 founded, Unfunded company
- Celltrion Pharm - Cheongju-si based, 2000 founded, Public company
- Allied Patients - Kailua based, 2018 founded, Deadpooled company
- Malvyn Pharmaceuticals - Thane based, 2016 founded, Deadpooled company